Drug Approval | August 07, 2025
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg
This is the group’s first NoC approval in Canada
This is the group’s first NoC approval in Canada
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
Cenexi reports an EBITDA breakeven for the quarter
The submission is supported by positive results from the Phase 3 AMPLIFY trial
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Vasograin Plus represents a major advancement in the treatment of migraine
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
This will be Aster’s fifth hospital in Bengaluru
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
Subscribe To Our Newsletter & Stay Updated
